Are sea sponges a key part of the complex solution to antimicrobial resistance? by Koch, M et al.
11/9/2021 Are sea sponges a key part of the complex solution to antimicrobial resistance? | Microbiology Society
https://microbiologysociety.org/publication/past-issues/oceans/article/are-sea-sponges-a-key-part-of-the-complex-solution-to-antimicrobial-resistance.html 1/4
ARE SEA SPONGES A KEY PART OF THE COMPLEX
SOLUTION TO ANTIMICROBIAL RESISTANCE?
Issue: Oceans
05 February 2019  ARTICLE
With the impending threat of antimicrobial resistance, now a widely-recognised phenomenon,
researchers have begun to look to the deep in search of solutions to one of the greatest threats posed to
human health. Boosted by public health initiatives, government endorsement and a concerted effort on
the part of researchers worldwide, we are now beginning to work towards potential alternatives to the
scenario outlined by Lord O’Neill in 2016 in the Review on Antimicrobial Resistance. But have we begun
to turn the tide?
Antimicrobial discovery, as part of the much-needed and multi-faceted approach to tackling
antimicrobial resistance (AMR), has necessitated that the search for novel compounds be widened to
new and unexplored environments. Sponges have emerged in recent decades as the most prolific source
of novel biological compounds from the marine environment. Over the last 45 years, sponges have
become the most widely sampled marine phyla in the hunt for novel bioactive compounds. Initially,
antimicrobial activity in sponge extracts was believed to be derived from the sponge itself, but the rediscovery of compounds across distinct
sponge species, as well as the similarity of the compounds to those observed in terrestrial micro-organisms has confirmed that many sponge
antimicrobials are in fact of microbial origin. For this reason, focus has shifted towards investigation of the microbial constituents of the
sponge microbiota. The use of metagenomics to characterise the microbial inhabitants of specific species, alongside efforts to culture these
sponge-associated microbes, is providing sponge researchers with an ever-growing bank of promising drug leads.
Sea sponges and their microenvironment
So what is it about sponges that make them and their resident microbes such
an ideal environment for the production of such exciting compounds?
Our story starts a mere 600 million years ago. The icy desolation of a frozen
earth is now a distant memory, multicellular life has transferred from MPhil to
PhD and the first ‘complex’, invertebrate organisms are beginning to emerge.
Enter the Porifera (sponges). Fast forward 600 million years and you arrive at
the existence of an ancient metazoan organism with a unique, complex
microbiota and a convergent evolution to be proud of. Sponges can be
categorised as either high or low microbial abundance species. With a
microbial abundance of 10  cells per gram of sponge tissue for ‘high
microbial abundance’ sponges, their complexity exceeds that of the
surrounding environment. This, combined with the knowledge that the sponge
microbiota is known to play an important role in a range of ecological
functions in the marine environment, makes it easier to imagine how the dynamic microenvironment of the sponge holobiont becomes such a
reservoir for new and interesting antimicrobials.
The characterisation of the global sponge microbiome has identified a generally conserved or ‘core’ microbiota across sponge species, albeit
with a high degree of interspecies variation. Proteobacteria, predominantly the Gammaproteobacteria, dominate the core microbiota,
accompanied by members of the Cyanobacteria, Acidobacteria and Actinobacteria. A look at the major producers of antimicrobial compounds
thus far from the sponge holobiont reveals that the Actinobacteria, specifically Streptomyces species, represent the most prolific producers of
antimicrobial agents (~27%), followed by Pseudovibrio (~18%).
Even with the conservation of the core sponge microbiota, there is a high degree of variability between sponge species, particularly in the
non-core, or lower-abundance bacterial species. It has been demonstrated that the sponge–host identity is the most important factor in
determining microbial composition, suggesting that there is still far more to be discovered by looking at under-studied species.
Exploring the deep
It is only with relatively recent advances in sampling technology, the use of remotely operated vehicles (ROVs) and submersible vehicles, that
the recovery of deeper water samples in good condition and from rocky seabeds, has been made possible. Previous to this, the only way to
sample deep-sea animals was using trawls and dredges which damaged specimens and restricted use to softer seabeds where nets would
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not be damaged during sampling. Even so, much of our study as been of those animals found h llower than 1,000 metres, where now we
are beginning to look deeper than this. Being able to sample these new environments provides access to more diverse sponges and brings
with it the promise of a wealth of novel strains and compounds.
The use of ROVs for deep-sea sample collection is allowing our research team at the University of Plymouth to conduct the first in-depth
investigations of a number of previously unstudied glass sponges (Hexactinellida), revealing information about their resident microbes and
biotechnological potential. Much of the work previously describing sponge microbiota and novel antimicrobial discovery has been focused on
sponges obtained from shallow waters. In addition, the Demosponge class of sponge has traditionally taken centre-stage in the hunt for novel
bioactives. Occurring almost exclusively below 200 metres depth, the glass sponges represent an extremely under-appreciated organism in
the ongoing search for bioactive molecules, particularly when considered in light of the knowledge that bacterial diversity in marine
environments is known to increase with depth.
Potential novel bioactive compounds
It is suggested that with novelty of sample comes novelty of associated biologics. This assumption, explored with the use of both culture-
dependent and -independent methods, is reinvigorating the quest for compounds in light of the ‘great plate anomaly’ (see box*), and in the
process unravelling the hidden relationship between the hexactinellid sponge microbiota and its propensity for bioactivity.
With regards to the role of sponges specifically in the context of tackling AMR, it is interesting to note that, as yet, none of the compounds
elicited by sponges or their microbiota have been translated into clinically approved antimicrobial drugs. Two compounds that have been
marketed are Ara-C, with anti-cancer activity, and the anti-viral agent Ara-A. The scale-up of bioactive production, particularly where agents
are sponge-derived, is hindered by a lack of biological material, yet theoretically this is more manageable where bacteria are the source.
This apparent disparity between the high number of discovered compounds and the number of approved therapies perhaps speaks of a wider
problem inherent in the strategies currently employed in bringing drug candidates from bench to bedside, or in this case from the seabed to
the bench. With large pharmaceutical companies reluctant to invest in antimicrobial development due to the low returns on investment, time-
scales involved and the inevitable threat of resistance; this brings with it additional challenges in progressing potential leads through the pre-
clinical pipeline.
Minimising the threat of AMR will undoubtedly require a multi-faceted approach, a key part of which will be provision of new classes of
antibiotic. It is clear that (deep) sea sponges and their microbiota represent an extremely rich and still underexplored environment, but
despite their bioactive productivity, there is still much to be discovered about these fascinating organisms. Their standing in the field of novel
antimicrobial discovery is yet to be fully revealed.
Further reading
Blunt J, Copp B, Keyzers R, Munro M, Prinsep M. Marine natural products. Nat Prod Rep 2017;34:235–294.
Thomas T, Moitinho-Silva L, Lurgi M, Björk J, Easson C et al. Diversity, structure and convergent evolution of the global sponge microbiome.
Nat Commun 2016;7:11870.
*The great plate anomaly
Where the number of micro-organisms identified using non-culture based methods,
like microscopy or molecular analyses, far exceeds the numbers that can be counted
growing on culture plates.
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drug discovery and span Amprologix out of the university in 2018 to further develop lead antimicrobial candidate epidermicin.
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What does a typical day (or week) involve for you?
Matthew: A typical week for me consists mainly of lab work, working with different sponge isolates and characterising the compounds they
produce. This currently involves working with a lot of different media, taking the bacteria through fermentation steps as well as
chromatography. Also involved in a week are analysing results, setting time aside to read papers and drinking my fair share of coffee.
What inspired you to become a microbiologist?
Matthew: The idea that somewhere out there in the global ecosystem exist the treatments for current (and future) health problems. I also
liked the idea that there were these tiny lifeforms hidden from view that were so complex and that did things I didn’t understand (and still
don’t!).
Image 1: Euplectella sp. sponge prior to sampling (~1,200 metres). Kerry Howell courtesy Eurofleets2–funded DeepMap project – University of
Plymouth, NUI Galway, Centre for Environment Fisheries and Aquaculture Science (Cefas), Marine Institute.
Image 2: Pheronema carpenteri in situ on the sea-floor (~1,200 metres). Kerry Howell courtesy Eurofleets2–funded DeepMap project –
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